Table 2. Antibiotic susceptibility patterns of non-fermenters.
Antimicrobial susceptibility patterns of NFGNB are illustrated as frequency and proportions
AN: amikacin, ATM: aztreonam, CAZ: ceftazidime, CIP: ciprofloxacin, CL: colistin, FEP: cefepime, GM: gentamicin, IPM: imipenem, LVX: levofloxacin, MEM: meropenem, CPS: cefoperazone-sulbactam, SXT: cotrimoxazole, TGC: tigecycline, TZP: piperacillin-tazobactam, NFGNB: non-fermenting Gram-negative bacteria
| Bacteria | AN | ATM | CAZ | CIP | CL | FEP | GM | IPM | LVX | MEM | CPS | SXT | TGC | TZP |
| Acinetobacter baumannii (n = 401) | ||||||||||||||
| Sensitive | 68 (17.0%) | 34 (8.5%) | 73 (18.2%) | 57 (14.2%) | 87 (21.7%) | 54 (13.5%) | 64 (16.0%) | 54 (13.5%) | 84 (20.9%) | 53 (13.2%) | 88 (21.9%) | 121 (30.1%) | 195 (48.6%) | 50 (12.5%) |
| Intermediate | 77 (19.2%) | 22 (5.5%) | 17 (4.2%) | 27 (6.7%) | 302 (75.3%) | 39 (9.7%) | 34 (8.4%) | 12 (3.0%) | 26 (6.5%) | 36 (9.0%) | 26 (6.5%) | 50 (12.5%) | 106 (26.4%) | 27 (6.7%) |
| Resistant | 256 (63.8%) | 345 (86.0%) | 311 (77.6%) | 317 (79.1%) | 12 (3.0%) | 308 (76.8%) | 303 (75.6%) | 335 (83.5%) | 291 (72.6%) | 312 (77.8%) | 287 (71.6%) | 230 (57.4%) | 100 (25.0%) | 324 (80.8%) |
| Pseudomonas aeruginosa (n = 248) | ||||||||||||||
| Sensitive | 169 (68.2%) | 192 (77.4%) | 129 (52.0%) | 104 (41.9%) | 103 (41.5%) | 144 (58.1%) | 108 (43.5%) | 128 (51.6%) | 85 (34.3%) | 95 (38.3%) | 106 (42.7%) | 15 (6.1%) | 95 (38.3%) | 120 (48.4%) |
| Intermediate | 10 (4.0%) | 25 (10.1%) | 24 (9.7%) | 51 (20.6%) | 130 (52.4%) | 38 (15.3%) | 61 (24.6%) | 37 (14.9%) | 73 (29.4%) | 57 (23.0%) | 57 (23.0%) | 48 (19.3%) | 35 (14.1%) | 44 (17.7%) |
| Resistant | 69 (27.8%) | 31 (12.5%) | 95 (38.3%) | 93 (37.5%) | 15 (6.1%) | 66 (26.6%) | 79 (31.9%) | 83 (33.5%) | 90 (36.3%) | 96 (38.7%) | 85 (34.3%) | 185 (74.6%) | 118 (47.6%) | 84 (33.9%) |
| Burkholderia cepacia (n = 108) | ||||||||||||||
| Sensitive | 28 (25.9%) | 45 (41.7%) | 49 (45.4%) | 34 (31.4%) | 0 | 38 (35.2%) | 24 (22.2%) | 41 (38.0%) | 12 (11.1%) | 36 (33.3%) | 50 (46.3%) | 6 (5.5%) | 60 (55.6%) | 27 (25.0%) |
| Intermediate | 13 (12.0%) | 35 (32.4%) | 23 (21.3%) | 37 (34.3%) | 7 (6.5%) | 44 (40.7%) | 51 (47.2%) | 32 (29.6%) | 17 (15.7%) | 37 (34.3%) | 36 (33.3%) | 38 (35.2%) | 27 (25.0%) | 34 (31.5%) |
| Resistant | 67 (62.1%) | 28 (25.9%) | 36 (33.3%) | 37 (34.3%) | 101 (93.5%) | 26 (24.1%) | 33 (30.6%) | 35 (32.4%) | 79 (73.2%) | 35 (32.4%) | 22 (20.4%) | 64 (59.3%) | 21 (19.4%) | 47 (43.5%) |